Home » New Drugs
0
Mylan has signed a settlement agreement with Pfizer to resolve litigation related to Caduet tablets.
What is Caduet? According to Drugs.com, Caduet contains a combination of amlodipine and atorvastatin. Atorvastatin is a HMG CoA reductase inhibitor,...
Continue Reading »
FDA approves Merck HPV vaccine for anal cancer, AIN prevention
The US Food and Drug Administration (FDA) has approved new indication for Merck’s Gardasil [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the...
Continue Reading »
FDA approves Novartis high BP drug Amturnide
The US Food and Drug Administration (FDA) has approved Novartis’ high blood pressure treatment, Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets on the basis of the data from a double-blind,...
Continue Reading »
Pfizer files supplemental applications to FDA and EMA for Prevnar 13
Pfizer has filed supplemental applications to the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13 (Pneumococcal 13-valent...
Continue Reading »
Malaria Vaccine it’s not a dream anymore.
Vivante GMP Solutions has completed process optimisation activities related to the upcoming production of a GMP clinical plot of an Oxford University adenovirus-based malaria vaccine.
The Jenner Institute...
Continue Reading »
On Sept. 14, 2009, the Innovative Medicines Initiative (IMI), a public–private partnership between the European Commission and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations...

